Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.2 USD | +1.20% | +2.69% | -23.64% |
May. 15 | Earnings Flash (MRKR) MARKER THERAPEUTICS Reports Q1 Revenue $1.2M | MT |
Apr. 30 | Ladenburg Thalmann Starts Marker Therapeutics With Buy Rating, $11 Price Target | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.64% | 37.44M | |
+41.79% | 54.04B | |
-0.56% | 41.92B | |
+49.17% | 41.96B | |
-7.20% | 28.35B | |
+12.59% | 26.35B | |
-21.51% | 19B | |
+6.92% | 13B | |
+24.91% | 12.19B | |
+29.60% | 12.28B |
- Stock Market
- Equities
- MRKR Stock
- News Marker Therapeutics, Inc.
- Transcript : Marker Therapeutics, Inc., Q1 2021 Earnings Call, May 12, 2021